M&T Bank

M&T Bank’s Xenon Pharmaceuticals XENE Stock Holding History

M&T Bank’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,251	Closed	-$115K	–	1766
2016 Q3	$115K	Buy	+14,251	New	+$110K	﹤0.01%	1545

Other funds holding XENE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

M&T Bank's XENE Position: Q4 2016 in Review

M&T Bank sold out of Xenon Pharmaceuticals (XENE) in Q4 2016, closing a stake of 14,251 shares — an estimated $115K sold.

M&T Bank first reported a position in XENE in Q3 2016 and held it in 1 quarter. The position peaked at $115K in Q3 2016. 31 funds tracked by Wall St. Rank hold XENE as of Q4 2016.

M&T Bank reported no remaining Xenon Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
M&T Bank sold 14,251 Xenon Pharmaceuticals shares in Q4 2016, an estimated $115K.
M&T Bank first reported a position in Xenon Pharmaceuticals in Q3 2016 and held it in 1 quarter.
M&T Bank's Xenon Pharmaceuticals position peaked at $115K in Q3 2016.
31 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2016.

Based on M&T Bank's 13F filing for Q4 2016, filed 14 Feb 2017.